Methyl-B12 and methylfolate

Updated June 3, 2026

Methylcobalamin and L-methylfolate are the active, ready-to-use forms of B12 and folate. They feed directly into the body's methylation cycle, donating methyl groups to build neurotransmitters, repair DNA, and clear homocysteine out of the bloodstream. For people who carry a reduced-activity MTHFR variant and run a sluggish methylation cycle, the active forms do real work the standard forms have to be converted into first. Roughly one in ten people of European ancestry carries the homozygous C677T variant, and the heterozygous form is far more common, which is why the methylated pair has become the default in psychiatric, cardiology-adjacent, and fertility clinics that pay attention to homocysteine.

Folate metabolism explains the case for the methylated forms. Folic acid, the synthetic form in fortified grains and cheap multivitamins, gets reduced in the enterocytes lining the small intestine. Dihydrofolate reductase converts it through dihydrofolate to tetrahydrofolate and finally to 5-methyltetrahydrofolate, the circulating form that crosses into cells. MTHFR catalyzes that last step. A reduced-activity variant slows it. Skipping straight to methylfolate hands the cell the finished product. For carriers with elevated homocysteine, the methylated forms produce measurable drops where standard folic acid stalls.

What the cycle produces is the real story. Methylfolate donates its methyl group to homocysteine, regenerating methionine, which gets activated to S-adenosylmethionine (SAMe), the universal methyl donor in human biochemistry. SAMe hands methyl groups to over a hundred methyltransferases, including the enzymes that build dopamine, serotonin, norepinephrine, and melatonin, the COMT enzyme that breaks catecholamines back down, and the DNA methyltransferases that lay down epigenetic marks. A poorly running cycle leaves homocysteine high and the SAMe-dependent machinery undersupplied. Treatment-resistant depression as a methylation problem makes more sense once you see that branch of the diagram.

The cardiovascular angle is where this matters most. Elevated homocysteine is a recognized cardiovascular risk marker, and a poorly methylating system lets it climb. If homocysteine runs over about 15 micromoles per liter and the MTHFR variant is present, switching to methylfolate plus methyl-B12 brings homocysteine down reliably in the published trials. Beyond the number on the lab report, homocysteine damages vascular endothelium, impairs nitric-oxide-dependent vasodilation, and accelerates oxidative injury to LDL particles. Bringing it back into range restores some of that endothelial function. If homocysteine is normal, the gain is smaller and harder to measure, and the cheaper forms still work fine for general intake.

B12 is the more interesting half of the pair. Cyanocobalamin is shelf-stable and cheap, but the body has to strip the cyanide group and rebuild the active cofactors. Methylcobalamin arrives ready for the methylation cycle. The other active cofactor, adenosylcobalamin, runs the mitochondrial reaction converting methylmalonyl-CoA to succinyl-CoA, feeding the TCA cycle and ATP production. When B12 runs low, methylmalonic acid accumulates and myelin synthesis falters, because the cycle also supplies the methyl groups that maintain the myelin sheath. That is why long-standing deficiency produces peripheral neuropathy and the cognitive slowing seen in older adults. For people with pernicious anemia (autoimmune destruction of intrinsic factor), oral or sublingual methylcobalamin at high doses, or injections, are the standard fix. For confirmed vegans, supplementation is not optional, because plant foods contain essentially none of the vitamin. Methylcobalamin or a mixed methyl/adenosyl form is the sensible pick, and the benefit is unambiguous: corrected serum B12, restored neurological function, normalized homocysteine. Lacto-ovo vegetarians sit in a softer middle, with dairy and eggs supplying meaningful B12, though intakes are often on the low end.

A 2018 Cochrane review tested the same question. High-dose oral cyanocobalamin at 1000 to 2000 micrograms per day raised serum B12 in most patients about as effectively as injections, even in older adults whose absorption was mildly impaired. The dose did the heavy lifting. The form was secondary. Methylcobalamin works equally well at the same range, with the bonus of skipping the intracellular conversion step.

Dosing in practice. For general support, 500 to 1000 micrograms of sublingual or oral methylcobalamin covers most people. Bump it to 1000 to 2000 if you are correcting a real deficiency. Methylfolate sits at 400 to 800 micrograms, which lines up with the folate RDA.

Psychiatry uses bigger numbers. The Deplin protocol prescribes L-methylfolate at 7.5 to 15 milligrams for treatment-resistant depression, where adding it to an SSRI consistently lifts the response rate. Different territory altogether, and a conversation that belongs with the prescriber.

Fertility clinics reach for the pair too, but for an upstream reason. DNA methylation patterns laid down during gametogenesis and early embryonic development depend on adequate SAMe supply. In MTHFR carriers, the methylated forms keep that supply steadier than folic acid.

The over-methylation complaint deserves an honest hearing. A subset of users, mostly at higher methylfolate doses, run into anxiety, irritability, insomnia, or headaches within days. The likely mechanism: SAMe production climbs faster than the surrounding neurotransmitter system recalibrates, and COMT activity has to catch up. Drop the dose, or switch to folinic acid (5-formyltetrahydrofolate), and the issue usually resolves. Smaller amounts work for some people. Milder than people fear, but real enough to flag.

Folic acid fortification deserves an honest mention. Mandatory fortification of grain products in the United States since 1998 cut neural tube defects by roughly a quarter to a third, with larger reductions when periconceptional supplementation is layered on top. The benefit is large and real. Whatever the methylated-versus-synthetic debate looks like for adult supplementation, fortification was one of the more successful public health interventions of recent decades.

A few safety details. Routine MTHFR genotyping is not recommended by the American College of Medical Genetics, but checking homocysteine and serum B12 directly is useful and inexpensive. Methylfolate can mask the hematologic signs of B12 deficiency while letting neurological damage progress, which is why B12 and folate are assessed together. If you take levodopa, certain seizure medications, or methotrexate, the interactions with folate metabolism are real and worth a conversation with the prescriber.

What the methylated pair earns you. Direct entry into the methylation cycle without depending on enzyme conversion. Reliable homocysteine reduction for MTHFR carriers and people with elevated levels. A working SAMe supply, meaning functional neurotransmitter synthesis, DNA methylation, and myelin maintenance. Corrected B12 status in vegans and pernicious anemia patients, one of the cleanest interventions in nutritional medicine. A useful adjunct in treatment-resistant depression at prescription doses. The active forms cost more, and for someone with normal homocysteine and no absorption issues, the cheaper forms cover the bases. For everyone the methylated forms are aimed at, the biochemistry and the outcomes line up.